Annu Söderholm

Title: Annu Söderholm: Innovator in Vascular Adhesion Protein Research

Introduction

Annu Söderholm is a prominent inventor based in Espoo, Finland. She has made significant contributions to the field of vascular adhesion proteins, particularly through her innovative research and patenting efforts. Her work focuses on the structural information of crystalline human VAP-1, which has important implications for medical research and drug development.

Latest Patents

Annu Söderholm holds a patent for her invention titled "Crystalline VAP-1 and uses thereof." This patent relates to crystalline vascular adhesion protein-1 (VAP-1) and outlines methods for utilizing structural information of crystalline human VAP-1 for ligand and/or inhibitor identification, design, and production. The invention also includes screening assays for the detection of inhibitors identified through these methods.

Career Highlights

Annu is associated with Biotie Therapies Corporation, where she continues to advance her research in the field of vascular adhesion proteins. Her work has garnered attention for its potential applications in therapeutic development and disease treatment.

Collaborations

Annu collaborates with notable colleagues, including Tomi Airenne and Yvonne Nymalm-Rejström. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.

Conclusion

Annu Söderholm's innovative work in vascular adhesion proteins exemplifies the impact of research on medical science. Her contributions through patenting and collaboration continue to pave the way for future advancements in this important area of study.